These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 29870900

  • 1. Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate.
    Yang J, Cao Q, Zhang H, Hao L, Zhou D, Gan Z, Li Z, Tong YX, Ji LN, Mao ZW.
    Biomaterials; 2018 Sep; 176():94-105. PubMed ID: 29870900
    [Abstract] [Full Text] [Related]

  • 2. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A, Dromparis P, Saleme B, Gurtu V, Watson K, Paulin R, Zervopoulos S, Stenson T, Sutendra G, Pink DB, Carmine-Simmen K, Moore R, Lewis JD, Michelakis ED.
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [Abstract] [Full Text] [Related]

  • 3. Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy.
    Wei G, Sun J, Luan W, Hou Z, Wang S, Cui S, Cheng M, Liu Y.
    J Med Chem; 2019 Oct 10; 62(19):8760-8772. PubMed ID: 31509699
    [Abstract] [Full Text] [Related]

  • 4. Targeting of two aspects of metabolism in breast cancer treatment.
    Gang BP, Dilda PJ, Hogg PJ, Blackburn AC.
    Cancer Biol Ther; 2014 Oct 10; 15(11):1533-41. PubMed ID: 25482950
    [Abstract] [Full Text] [Related]

  • 5. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.
    Pathak RK, Marrache S, Harn DA, Dhar S.
    ACS Chem Biol; 2014 May 16; 9(5):1178-87. PubMed ID: 24617941
    [Abstract] [Full Text] [Related]

  • 6. Simultaneously Inducing and Tracking Cancer Cell Metabolism Repression by Mitochondria-Immobilized Rhenium(I) Complex.
    Yang J, Zhao JX, Cao Q, Hao L, Zhou D, Gan Z, Ji LN, Mao ZW.
    ACS Appl Mater Interfaces; 2017 Apr 26; 9(16):13900-13912. PubMed ID: 28368110
    [Abstract] [Full Text] [Related]

  • 7. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL, Park JY, Kim EH, Jang HJ, Kwon M.
    Cancer Lett; 2016 Feb 01; 371(1):20-9. PubMed ID: 26607904
    [Abstract] [Full Text] [Related]

  • 8. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA, De Preter G, Joudiou N, Bol A, Brender JR, Saito K, Kishimoto S, Grégoire V, Jordan BF, Krishna MC, Feron O, Gallez B.
    Oncotarget; 2016 Dec 06; 7(49):81741-81749. PubMed ID: 28082726
    [Abstract] [Full Text] [Related]

  • 9. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
    Stockwin LH, Yu SX, Borgel S, Hancock C, Wolfe TL, Phillips LR, Hollingshead MG, Newton DL.
    Int J Cancer; 2010 Dec 01; 127(11):2510-9. PubMed ID: 20533281
    [Abstract] [Full Text] [Related]

  • 10. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
    Ruggieri V, Agriesti F, Scrima R, Laurenzana I, Perrone D, Tataranni T, Mazzoccoli C, Lo Muzio L, Capitanio N, Piccoli C.
    Oncotarget; 2015 Jan 20; 6(2):1217-30. PubMed ID: 25544754
    [Abstract] [Full Text] [Related]

  • 11. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
    Ferrarini MG, Nisimura LM, Girard RMBM, Alencar MB, Fragoso MSI, Araújo-Silva CA, Veiga AA, Abud APR, Nardelli SC, Vommaro RC, Silber AM, France-Sagot M, Ávila AR.
    mSphere; 2021 Jan 06; 6(1):. PubMed ID: 33408226
    [Abstract] [Full Text] [Related]

  • 12. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A, Kant S, Singh SM.
    Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):196-208. PubMed ID: 24051182
    [Abstract] [Full Text] [Related]

  • 13. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
    Schoonjans CA, Joudiou N, Brusa D, Corbet C, Feron O, Gallez B.
    Cancer Lett; 2020 Feb 01; 470():18-28. PubMed ID: 31812695
    [Abstract] [Full Text] [Related]

  • 14. Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis.
    Al-Azawi A, Sulaiman S, Arafat K, Yasin J, Nemmar A, Attoub S.
    Int J Mol Sci; 2021 Nov 21; 22(22):. PubMed ID: 34830434
    [Abstract] [Full Text] [Related]

  • 15. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H, Decollogne S, Dilda PJ, Hau E, Chung SA, Luk PP, Hogg PJ, McDonald KL.
    J Exp Clin Cancer Res; 2015 Feb 05; 34(1):14. PubMed ID: 25652202
    [Abstract] [Full Text] [Related]

  • 16. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
    Tataranni T, Agriesti F, Pacelli C, Ruggieri V, Laurenzana I, Mazzoccoli C, Sala GD, Panebianco C, Pazienza V, Capitanio N, Piccoli C.
    Cells; 2019 May 18; 8(5):. PubMed ID: 31109089
    [Abstract] [Full Text] [Related]

  • 17. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer.
    Sutendra G, Dromparis P, Kinnaird A, Stenson TH, Haromy A, Parker JM, McMurtry MS, Michelakis ED.
    Oncogene; 2013 Mar 28; 32(13):1638-50. PubMed ID: 22614004
    [Abstract] [Full Text] [Related]

  • 18. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
    Choi YW, Lim IK.
    Cancer Lett; 2014 May 01; 346(2):300-8. PubMed ID: 24480191
    [Abstract] [Full Text] [Related]

  • 19. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
    Hur H, Xuan Y, Kim YB, Lee G, Shim W, Yun J, Ham IH, Han SU.
    Int J Oncol; 2013 Jan 01; 42(1):44-54. PubMed ID: 23135628
    [Abstract] [Full Text] [Related]

  • 20. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro.
    Harting T, Stubbendorff M, Willenbrock S, Wagner S, Schadzek P, Ngezahayo A, Murua Escobar HM, Nolte I.
    Int J Oncol; 2016 Dec 01; 49(6):2341-2350. PubMed ID: 27748833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.